Pulmotree is a young, dynamic life-science startup based in Munich, Germany. Driven by new ideas, we are forward-thinking in patient treatments – and with many years of consulting expertise, the entire industry.
Reducing risks with the Pulmotree Kolibri by adherence monitoring and inhalation technique analysis.
Highly efficient drug delivery and maximum support for patient and caregiver. The Pulmotree Kolibri is the evolution of aerosol therapy.
Adding value and protection with our innovative key & lock technology.
With the Pulmotree Kolibri platform together and at eye level for optimal aerosol therapy.
27. June – 28. June 2024, Barcelona, Spain
Speaker: Ulf Krueger
Title: “Connectivity and remote monitoring in nebulized therapies: a look into the future?”
07. – 11. September. 2024, Vienna, Austria
Poster Presenter: Carolina Dantas
Delegate: Ulf Krueger
Title: “Guided inhalation manoeuvre during nebulisation – tracking and analysing users’ breathing technique”
11. – 13. September. 2024, Parma, Italy
Exploring the Future of Inhalation Drug Delivery 2024
Poster Presenter: Carolina Dantas
Delegate: Ulf Krueger
Title: “Assessing the impact of using realistic breathing profiles for regional lung deposition models”
19. – 20. September 2024, Berlin
Chairman and Speaker: Ulf Krueger
Title: “To be announced”
26. September – 27. September 2024, Cambridge, UK
Speaker: Carolina Dantas
Title: “Vibrating Mesh Nebulizers: insights into the delivery of biologics”
21. November – 22. November 2024, Prague, Czech Republic (New venue and date)
Conference Chairman & Speaker: Ulf Krueger
Title: “The impact of the breathing maneuver in nebulized therapy – guided inhalation technology and its effect on pulmonary drug delivery“
11. December – 13. December 2024, Edinburgh, Scotland
Delegates: Ulf Krueger and Carolina Dantas
WIPANO
BUNDESMINISTERIUM FÜR WIRTSCHAFT UND ENERGIE
BAYERISCHE BETEILIGUNGSGESELLSCHAFT